Patterns of synthetic cannabinoid use in Australia.

作者: Monica J. Barratt , Vince Cakic , Simon Lenton

DOI: 10.1111/J.1465-3362.2012.00519.X

关键词: Synthetic cannabinoidsInterquartile rangeInjury preventionDemographySuicide preventionPsychiatryOccupational safety and healthDrugPoison controlCannabisMedicine

摘要: INTRODUCTION AND AIMS: To assess the demographic profile, use patterns, market characteristics, reasons for first and self-reported harms associated with of synthetic cannabinoids in Australia. DESIGN METHODS: An online questionnaire was administered to a purposive sample 316 Australian cannabinoid users [96% cannabis users, 77% male, median age 27 years, interquartile range (IQR) 23-34] who drug characteristics. RESULTS: The duration 6 months (IQR 2-10), 35% reported weekly or more often 7% daily use. Reasons included curiosity (50%), legality (39%), availability (23%), recreational effects (20%), therapeutic (9%), non-detection standard screening assays (8%) aid reduction cessation (5%). Users buying 3 g 3-6) paying AU$60 37-90). Most (68%) at least one side-effect during their last session use, including decreased motor co-ordination fast irregular heartbeat (33%), dissociation (22%), dizziness paranoia (18%) psychosis (4%). 4 respondents seeking help. A greater number side-effects were by males, those aged 18-25 water pipe ('bong') concurrent alcohol drinkers. DISCUSSION CONCLUSIONS: using due curiosity, legality, availability, effects, testing reduce Harms widely yet help-seeking minimal. Inclusion questions regarding household surveys is warranted. Language: en

参考文章(18)
Liana Fattore, Walter Fratta, Beyond THC: The New Generation of Cannabinoid Designer Drugs Frontiers in Behavioral Neuroscience. ,vol. 5, pp. 60- 60 ,(2011) , 10.3389/FNBEH.2011.00060
Susanna Every-Palmer, Synthetic cannabinoid JWH-018 and psychosis: An explorative study Drug and Alcohol Dependence. ,vol. 117, pp. 152- 157 ,(2011) , 10.1016/J.DRUGALCDEP.2011.01.012
Ryan Vandrey, Kelly E. Dunn, Jeannie A. Fry, Elizabeth R. Girling, A survey study to characterize use of Spice products (synthetic cannabinoids) Drug and Alcohol Dependence. ,vol. 120, pp. 238- 241 ,(2012) , 10.1016/J.DRUGALCDEP.2011.07.011
Wayne Hall, Louisa Degenhardt, None, Medical marijuana initiatives : are they justified? How successful are they likely to be? CNS Drugs. ,vol. 17, pp. 689- 697 ,(2003) , 10.2165/00023210-200317100-00001
Fabrizio Schifano, Ornella Corazza, Paolo Deluca, Zoe Davey, Lucia Di Furia, Magi' Farre', Liv Flesland, Miia Mannonen, Stefania Pagani, Teuvo Peltoniemi, Cinzia Pezzolesi, Norbert Scherbaum, Holger Siemann, Arvid Skutle, Marta Torrens, Peer Van Der Kreeft, Psychoactive drug or mystical incense? Overview of the online available information on Spice products International Journal of Culture and Mental Health. ,vol. 2, pp. 137- 144 ,(2009) , 10.1080/17542860903350888
Anne M. Bowen, Candice M. Daniel, Mark L. Williams, Grayson L. Baird, Identifying Multiple Submissions in Internet Research: Preserving Data Integrity AIDS and Behavior. ,vol. 12, pp. 964- 973 ,(2008) , 10.1007/S10461-007-9352-2
Christopher O. Hoyte, Jeena Jacob, Andrew A. Monte, Mohammed Al-Jumaan, Alvin C. Bronstein, Kennon J. Heard, A Characterization of Synthetic Cannabinoid Exposures Reported to the National Poison Data System in 2010 Annals of Emergency Medicine. ,vol. 60, pp. 435- 438 ,(2012) , 10.1016/J.ANNEMERGMED.2012.03.007
K. Brown, New Zealand bans synthetic cannabinoids BMJ. ,vol. 343, pp. d5395- d5395 ,(2011) , 10.1136/BMJ.D5395
Kathryn A. Seely, Jeff Lapoint, Jeffery H. Moran, Liana Fattore, Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids Progress in Neuro-psychopharmacology & Biological Psychiatry. ,vol. 39, pp. 234- 243 ,(2012) , 10.1016/J.PNPBP.2012.04.017
I. Vardakou, C. Pistos, Ch. Spiliopoulou, Spice drugs as a new trend: Mode of action, identification and legislation Toxicology Letters. ,vol. 197, pp. 157- 162 ,(2010) , 10.1016/J.TOXLET.2010.06.002